Organon & Co | OGN - Ebitda

Биржевая цена
11.26
Изменение за день
2.66 30.93%
Ежемесячно
84.59%
Ежегодный
-7.82%
Q2 прогноз
11.02




Ebitda Изменить Дата
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Celltrion KRW 374.56B 352.67B 2025-09
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Deva Holding AS TRY 882.9M 201.7M 2023-09
Dianthus Therapeutics USD -40.19M 5.36M 2025-09
Divis Laboratories Ltd INR 8.9B 20M 2025-12
Gilead Sciences USD 3.02B 1.01B 2025-12
Glaxosmithkline GBP 4.75B 1.52B 2025-09
Kangmei Pharma CNY 17.3M 20.56M 2025-06
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Laboratorios Farma EUR 34.94M 102.95M 2025-06
Malin Corporation EUR -1.1M 200K 2024-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Merck USD 8.39B 1.97B 2025-09
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
Novartis USD 5.84B 235M 2025-09
Organigram Holdings CAD 5.26M 884K 2025-12
Organon & Co USD 383M 135M 2025-12
Pharma Mar EUR 44.96M 46.94M 2025-12
Qiagen NV USD 249.69M 56.53M 2025-12
Sartorius EUR 267.3M 10.1M 2026-03
Sino Biopharmaceutical CNY 2.59B 1.57B 2024-12
Tilray USD 8.36M 1.82M 2025-09
Zealand Pharma A/S -727.47M 285.54M 2025-12